bpc 157 thymosin beta 4 vs Beta‑4: What I Actually Use Each For Thymosin Beta-4 (TB-4) and BPC-157

Reclassification does not mean the peptide has been approved by the FDA as a finished drug product

One human study examined 16 patients receiving intra-articular knee injections of 4000 mcg BPC-157 for various causes of knee pain

Use bacteriostatic (not plain sterile) water for a multi-dose vial so the preservative supports the multi-draw window, and reconstitute gently down the vial wall rather than blasting the powder

Review Methodology and Evidence Standards Applied The evaluation in this article is based on the following sources: the official ProHealth product page at prohealth.com, the Supplement Facts label as published (REV.04.25), the brand's published FAQ and company background materials, published research cited on the product page, and publicly available scientific literature on BPC-157's regulatory and research status